About Mark Migueis

Mark Migueis is a MedTech industry expert and investor with 20+ years of experience spanning research and development, corporate leadership and entrepreneurship.

Motivated by his father’s hardship with epilepsy, Mark helped to build the 1st imaging system to capture brain injuries in newborns in Canada during his university studies. A graduate of the biomedical engineering program at ETH Zürich, Mark led a business unit at Roche that secured its right to sell 60+ products in global markets, generating yearly revenue of 7+ billion CHF. In recent years, he founded a MedTech start-up that helped doctors in diagnosing patients with rare diseases using AI agents.

In his day-to-day life, Mark combines his work as an advisor to sophisticated investors on MedTech investments and his role as strategic advisor for companies with his own investments that back the next generation of tech-enabled healthcare champions.

To support the next wave of MedTech breakthroughs, Mark invests in companies focused in the following areas:

(1) in vivo medical devices that measure physiological parameters

(2) Passports that compile genetic, biological and physiological data and create personalized models of physiological systems

(3) Genetic, biological or physiological markers that push the time limits of detecting diseases

Contact: info@medtech-investments.com